Palliative Care Interventions for Outpatients With Newly Diagnosed Lung Cancer
40 Years
N/A
Both
Lung Cancer
Trial Information
Palliative Care Interventions for Outpatients With Newly Diagnosed Lung Cancer
Patients meeting entry criteria will be randomized to the intervention arm, palliative care
plus usual care or the usual care arm. Patients randomized to the intervention arm will
receive usual oncologic care and phone calls from a nurse. Outcomes measures will be
collected at baseline, and 3 months.
The study will be performed at the VA Puget Sound Health Care System. We will recruit
individuals (n=40) with lung cancer over 1 year. The primary objective is to test the
feasibility and acceptability of the intervention, and recruitment of subjects. We will
estimate the effect of a nurse-led telephone based palliative care intervention to improve
quality-of-life, symptom burden and patient satisfaction. In addition, using validated
instruments, we will assess the potential effect size of the intervention on quality of
provider communication and on clinician knowledge of patient preferences for life sustaining
therapies. The results of this pilot study will inform a future randomized clinical trial to
test the efficacy of the intervention on a larger scale.
Inclusion Criteria:
- Patients diagnosed at the Puget Sound Health Care System with a primary diagnosis of
lung cancer, any cell type or stage, diagnosed within 8 weeks of study enrollment.
- Must have telephone access, ability of understand English and provide informed
consent.
Exclusion Criteria:
- Patients not eligible to participate in the study include those who are inpatients
prior to randomization, those who are under the care of palliative care or hospice at
the time of randomization, those who have severe mental health disorders, those who
are unable to speak directly with the nurse over the telephone, or those that have
the inability to provide informed consent.
- We will recruit individuals (n=40) with lung cancer over a 12 month period using a
similar approach that we
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Patient Quality of Life including symptoms
Outcome Description:
Patient Quality of Life including symptoms as measured by the FACT-L
Outcome Time Frame:
3 months
Safety Issue:
No
Principal Investigator
Lynn F. Reinke, PhD ARNP
Investigator Role:
Principal Investigator
Investigator Affiliation:
VA Puget Sound Health Care System
Authority:
United States: Federal Government
Study ID:
NRI 12-141
NCT ID:
NCT01883986
Start Date:
October 2013
Completion Date:
April 2015
Related Keywords:
- Lung Cancer
- palliative care
- Lung Neoplasms
Name | Location |
|---|---|
| VA Puget Sound Health Care System | Seattle, Washington 98101 |
